Pontillo G, Prados F, Wink AM, Kanber B, Bisecco A, Broeders TAA, Brunetti A, Cagol A, Calabrese M, Castellaro M, Cocozza S, Colato E, Collorone S, Cortese R, De Stefano N, Douw L, Enzinger C, Filippi M, Foster MA, Gallo A, Gonzalez-Escamilla G, Granziera C, Groppa S, Harbo HF, Høgestøl EAet al.(2025) More Than the Sum of Its Parts: Disrupted Core Periphery of Multiplex Brain Networks in Multiple Sclerosis Hum Brain Mapp, 46(1), e70107 DOI 10.1002/hbm.70107, PubMed 39740239
Rød BE, Høgestøl EA, Torkildsen Ø, Bjørnevik K, Gran JM, Øverås MH, König M, Myhr KM, Wergeland S, Nygaard GO(2025) Comparative effectiveness of rituximab and cladribine in relapsing-remitting multiple sclerosis: A target trial emulation Mult Scler, 13524585251342727(in press) DOI 10.1177/13524585251342727, PubMed 40415655
Skattebøl L, Nygaard GO, Leonardsen EH, Kaufmann T, Moridi T, Stawiarz L, Ouellette R, Ineichen BV, Ferreira D, Muehlboeck JS, Beyer MK, Sowa P, Manouchehrinia A, Westman E, Olsson T, Celius EG, Hillert J, Kockum I, Harbo HF, Piehl F, Granberg T, Westlye LT, Høgestøl EA(2025) Brain age in multiple sclerosis: a study with deep learning and traditional machine learning Brain Commun, 7(3), fcaf152 DOI 10.1093/braincomms/fcaf152, PubMed 40337466